CRIO, Inc., a leading provider of eSource and other eClinical technologies, announced that it has received a significant investment from The Riverside Company, a global growth oriented private equity firm. CRIO’s industry-leading eClinical platform is designed to streamline research at the site-level, with fully integrated eSource, site CTMS, eConsent, EDC, remote monitoring, and source data verification solutions. CRIO’s platform provides research sites, sponsors and CROs with compelling value, and has rapidly attracted a large and growing base of hundreds of customers.
Read the full article: CRIO Poised for Continued Expansion Following Significant Investment by The Riverside Company //
Source: https://www.businesswire.com/news/home/20240521284192/en/CRIO-Poised-for-Continued-Expansion-Following-Significant-Investment-by-The-Riverside-Company